USD 0.33
(-23.27%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.52 Million USD | 399.42% |
2022 | 504.9 Thousand USD | -38.87% |
2021 | 826.02 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q1 | 510.54 Thousand USD | 341.5% |
2023 FY | 2.52 Million USD | 399.42% |
2023 Q4 | 1.26 Million USD | 235.26% |
2023 Q3 | 377.71 Thousand USD | 2.92% |
2023 Q2 | 366.99 Thousand USD | -28.12% |
2022 Q2 | 122.68 Thousand USD | -23.33% |
2022 Q1 | 160.03 Thousand USD | 0.0% |
2022 FY | 504.9 Thousand USD | -38.87% |
2022 Q4 | 115.63 Thousand USD | 8.53% |
2022 Q3 | 106.55 Thousand USD | -13.15% |
2021 Q3 | 80.00 USD | -96.02% |
2021 Q2 | 2010.00 USD | 0.0% |
2021 FY | 826.02 Thousand USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alignment Healthcare, Inc. | 328.84 Million USD | 99.233% |
Clover Health Investments, Corp. | 1.98 Billion USD | 99.873% |
Marpai, Inc. | 35.39 Million USD | 92.875% |